Liquidia Corporation (LQDA) Revenue History
Annual and quarterly revenue from 2016 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2020)
LQDA's revenue distribution by segment and geography for fiscal year 2020
By Product/Segment
LQDA Revenue Analysis (2016–2024)
As of March 2, 2026, Liquidia Corporation (LQDA) generated trailing twelve-month (TTM) revenue of $69.2 million, reflecting explosive growth of +1121.7% year-over-year. The most recent quarter (Q3 2025) recorded $54.3 million in revenue, up 514.9% sequentially.
Looking at the longer-term picture, LQDA's 5-year compound annual growth rate (CAGR) stands at +11.6%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $17.5 million in 2023.
Revenue diversification analysis shows LQDA's business is primarily driven by Promotion Agreement (100%), and Research and Development Services (0%). With over half of revenue concentrated in Promotion Agreement, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including UTHR (+10.6% YoY), ZLAB (+15.3% YoY), and AMRN (-6.2% YoY), LQDA has outperformed the peer group in terms of revenue growth. Compare LQDA vs UTHR →
Peer Comparison
Compare LQDA's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LQDACurrent | $69M | +1121.7% | +11.6% | -866.6% | |
| UTHR | $3.2B | +10.6% | +16.5% | 46.9% | |
| ZLAB | $460M | +15.3% | +56.5% | -49.9% | |
| AMRN | $229M | -6.2% | -11.9% | -40.2% | |
| ALKS | $1.5B | -5.2% | +7.3% | 17.2% | |
| ADMA | $426M | +27.6% | +70.8% | 32.6% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $14.0M | -20.0% | $8.1M | 58.0% | $-121,294,000 | -866.6% |
| 2023 | $17.5M | +9.7% | $14.6M | 83.5% | $-73,384,000 | -419.6% |
| 2022 | $15.9M | +24.0% | $13.1M | 82.1% | $-38,770,000 | -243.3% |
| 2021 | $12.9M | +1637.8% | $9.8M | 76.5% | $-33,797,000 | -263.0% |
| 2020 | $740K | -90.8% | $502K | 67.9% | $-59,089,130 | -7989.0% |
| 2019 | $8.1M | +198.2% | $7.3M | 90.0% | $-46,823,549 | -580.1% |
| 2018 | $2.7M | -62.7% | $2.6M | 95.5% | $-34,868,074 | -1288.1% |
| 2017 | $7.3M | -45.1% | $6.9M | 95.6% | $-28,028,286 | -386.2% |
| 2016 | $13.2M | - | $12.3M | 93.0% | $-15,862,803 | -120.0% |
See LQDA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LQDA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare LQDA vs AGIO
See how LQDA stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is LQDA's revenue growth accelerating or slowing?
LQDA revenue is accelerating at +1121.7% year-over-year, exceeding the 5-year CAGR of +11.6%. TTM revenue reached $69M. Growth momentum has increased versus prior periods.
What is LQDA's long-term revenue growth rate?
Liquidia Corporation's 5-year revenue CAGR of +11.6% reflects the sustained expansion pattern. Current YoY growth of +1121.7% is above this long-term average.
How is LQDA's revenue distributed by segment?
LQDA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2024 are available for download. Segment mix reveals concentration and diversification trends.